241 related articles for article (PubMed ID: 9794804)
1. Inhibition of the intrinsic NAD+ glycohydrolase activity of CD38 by carbocyclic NAD analogues.
Wall KA; Klis M; Kornet J; Coyle D; Amé JC; Jacobson MK; Slama JT
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):631-6. PubMed ID: 9794804
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of NAD glycohydrolase and ADP-ribosyl transferases by carbocyclic analogues of oxidized nicotinamide adenine dinucleotide.
Slama JT; Simmons AM
Biochemistry; 1989 Sep; 28(19):7688-94. PubMed ID: 2532931
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and properties of photoaffinity labels for the pyridine dinucleotide binding site of NAD glycohydrolase.
Slama JT; Simmons AM
Biochemistry; 1991 Mar; 30(9):2527-34. PubMed ID: 1848099
[TBL] [Abstract][Full Text] [Related]
4. Unifying mechanism for Aplysia ADP-ribosyl cyclase and CD38/NAD(+) glycohydrolases.
Cakir-Kiefer C; Muller-Steffner H; Schuber F
Biochem J; 2000 Jul; 349(Pt 1):203-10. PubMed ID: 10861229
[TBL] [Abstract][Full Text] [Related]
5. Probing Aplysia californica adenosine 5'-diphosphate ribosyl cyclase for substrate binding requirements: design of potent inhibitors.
Migaud ME; Pederick RL; Bailey VC; Potter BV
Biochemistry; 1999 Jul; 38(28):9105-14. PubMed ID: 10413485
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of ADP-ribosyl cyclase activity of the cell surface antigen CD38 by zinc ions resulting from inhibition of its NAD+ glycohydrolase activity.
Kukimoto I; Hoshino S; Kontani K; Inageda K; Nishina H; Takahashi K; Katada T
Eur J Biochem; 1996 Jul; 239(1):177-82. PubMed ID: 8706705
[TBL] [Abstract][Full Text] [Related]
7. Human CD38 is an authentic NAD(P)+ glycohydrolase.
Berthelier V; Tixier JM; Muller-Steffner H; Schuber F; Deterre P
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1383-90. PubMed ID: 9494110
[TBL] [Abstract][Full Text] [Related]
8. Kinetic competence of the cADP-ribose-CD38 complex as an intermediate in the CD38/NAD+ glycohydrolase-catalysed reactions: implication for CD38 signalling.
Cakir-Kiefer C; Muller-Steffner H; Oppenheimer N; Schuber F
Biochem J; 2001 Sep; 358(Pt 2):399-406. PubMed ID: 11513738
[TBL] [Abstract][Full Text] [Related]
9. Enzyme properties of Aplysia ADP-ribosyl cyclase: comparison with NAD glycohydrolase of CD38 antigen.
Inageda K; Takahashi K; Tokita K; Nishina H; Kanaho Y; Kukimoto I; Kontani K; Hoshino S; Katada T
J Biochem; 1995 Jan; 117(1):125-31. PubMed ID: 7775378
[TBL] [Abstract][Full Text] [Related]
10. Photodependent inhibition of bovine spleen NAD+ glycohydrolase by 8-azido carbocyclic analogs of NAD+.
Muller-Steffner H; Slama J; Schuber F
Biochem Biophys Res Commun; 1996 Nov; 228(1):128-33. PubMed ID: 8912647
[TBL] [Abstract][Full Text] [Related]
11. Nicotinamide 2-fluoroadenine dinucleotide unmasks the NAD+ glycohydrolase activity of Aplysia californica adenosine 5'-diphosphate ribosyl cyclase.
Zhang B; Muller-Steffner H; Schuber F; Potter BV
Biochemistry; 2007 Apr; 46(13):4100-9. PubMed ID: 17341094
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and functional expression of bovine spleen ecto-NAD+ glycohydrolase: structural identity with human CD38.
Augustin A; Muller-Steffner H; Schuber F
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):43-52. PubMed ID: 10600637
[TBL] [Abstract][Full Text] [Related]
13. Cell surface antigen CD38 identified as ecto-enzyme of NAD glycohydrolase has hyaluronate-binding activity.
Nishina H; Inageda K; Takahashi K; Hoshino S; Ikeda K; Katada T
Biochem Biophys Res Commun; 1994 Sep; 203(2):1318-23. PubMed ID: 8093047
[TBL] [Abstract][Full Text] [Related]
14. Identification of the enzymatic active site of CD38 by site-directed mutagenesis.
Munshi C; Aarhus R; Graeff R; Walseth TF; Levitt D; Lee HC
J Biol Chem; 2000 Jul; 275(28):21566-71. PubMed ID: 10781610
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of NAD+ glycohydrolase and ADP-ribosyl cyclase activities of leukocyte cell surface antigen CD38 by gangliosides.
Hara-Yokoyama M; Kukimoto I; Nishina H; Kontani K; Hirabayashi Y; Irie F; Sugiya H; Furuyama S; Katada T
J Biol Chem; 1996 May; 271(22):12951-5. PubMed ID: 8662799
[TBL] [Abstract][Full Text] [Related]
16. Mechanism-based inhibitors of CD38: a mammalian cyclic ADP-ribose synthetase.
Sauve AA; Schramm VL
Biochemistry; 2002 Jul; 41(26):8455-63. PubMed ID: 12081495
[TBL] [Abstract][Full Text] [Related]
17. Complex gangliosides as cell surface inhibitors for the ecto-NAD+ glycohydrolase of CD38.
Hara-Yokoyama M; Nagatsuka Y; Katsumata O; Irie F; Kontani K; Hoshino S; Katada T; Ono Y; Fujita-Yoshigaki J; Sugiya H; Furuyama S; Hirabayashi Y
Biochemistry; 2001 Jan; 40(4):888-95. PubMed ID: 11170409
[TBL] [Abstract][Full Text] [Related]
18. Coordinated regulation in human T cells of nucleotide-hydrolyzing ecto-enzymatic activities, including CD38 and PC-1. Possible role in the recycling of nicotinamide adenine dinucleotide metabolites.
Deterre P; Gelman L; Gary-Gouy H; Arrieumerlou C; Berthelier V; Tixier JM; Ktorza S; Goding J; Schmitt C; Bismuth G
J Immunol; 1996 Aug; 157(4):1381-8. PubMed ID: 8759717
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of cyclic ADP-ribose: Zinc is an endogenous modulator of the cyclase/NAD glycohydrolase ratio of a CD38-like enzyme from human seminal fluid.
Zielinska W; Barata H; Chini EN
Life Sci; 2004 Feb; 74(14):1781-90. PubMed ID: 14741735
[TBL] [Abstract][Full Text] [Related]
20. Crystallographic studies on human BST-1/CD157 with ADP-ribosyl cyclase and NAD glycohydrolase activities.
Yamamoto-Katayama S; Ariyoshi M; Ishihara K; Hirano T; Jingami H; Morikawa K
J Mol Biol; 2002 Feb; 316(3):711-23. PubMed ID: 11866528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
